Growth Metrics

Steris (STE) Cash from Financing Activities (2018 - 2025)

Steris has reported Cash from Financing Activities over the past 8 years, most recently at -$98.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$98.0 million for Q4 2025, up 54.29% from a year ago — trailing twelve months through Dec 2025 was -$648.4 million (up 57.85% YoY), and the annual figure for FY2025 was -$1.6 billion, down 1745.8%.
  • Cash from Financing Activities for Q4 2025 was -$98.0 million at Steris, up from -$159.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for STE hit a ceiling of $818.8 million in Q2 2021 and a floor of -$998.9 million in Q2 2024.
  • Median Cash from Financing Activities over the past 5 years was -$179.5 million (2024), compared with a mean of -$130.4 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 945.22% in 2021 and later surged 1146.13% in 2023.
  • Steris' Cash from Financing Activities stood at -$189.3 million in 2021, then surged by 36.38% to -$120.4 million in 2022, then crashed by 64.43% to -$198.0 million in 2023, then fell by 8.29% to -$214.4 million in 2024, then soared by 54.29% to -$98.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$98.0 million (Q4 2025), -$159.2 million (Q3 2025), and -$213.1 million (Q2 2025) per Business Quant data.